Table:
begin	end	state
1	32	cytoplasmic
33	52	transmembrane
53	62	non-cytoplasmic
63	80	transmembrane
81	87	cytoplasmic
88	109	transmembrane
110	125	non-cytoplasmic
126	143	transmembrane
144	154	cytoplasmic
155	178	transmembrane
179	183	non-cytoplasmic
184	211	transmembrane
212	222	cytoplasmic
223	241	transmembrane
242	276	non-cytoplasmic
277	296	transmembrane
297	300	cytoplasmic
301	320	transmembrane
321	335	cytoplasmic
336	356	transmembrane
357	361	non-cytoplasmic
362	385	transmembrane
386	428	cytoplasmic
429	450	transmembrane
451	451	non-cytoplasmic

Input:
>BWI76_RS04555
MSTTDNAFPATIDPINTPKAPLKQRWWHILDNWKVGIIPLPLFLLAGGLIALDCLGGKLP
SDIVVMVATLAFFGFACGEFGKRLPILGKLGAAAICATFIPSALVHYGLLPDVVVESTTK
FYKSTNILYLYICCIIVGSIMSMNRTTLIQGFMRIFFPMLCGEIVGMVVGVGVGTALGLE
PFQVFFFIVLPIMAGGVGEGAIPLSIGYAALMHMDQGVALGRVLPMVMLGSLTAIVIAGG
LNQLGKRFPHLTGEGQLMPNRRNETHRETPAEGKMDVTTLASGALLAVLLYMLGMLGQKT
IGLPAPVGMLFLAVLLKLVNGVSPRLQEGSQMVYKFFRTAVTYPILFAVGVAITPWQELV
NAFTLTNLLVIISTVSALVATGFLVGKKIGMHPIDVAIVSCCQSGQGGTGDVAILTSGNR
MNLMPFAQIATRIGGAINVSLGLLFLSHFLA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server